Compugen Ltd.
CGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $137 | $175 | $62 | $362 |
| - Cash | $18 | $14 | $11 | $8 |
| + Debt | $3 | $1 | $2 | $3 |
| Enterprise Value | $122 | $163 | $53 | $357 |
| Revenue | $28 | $33 | $8 | $6 |
| % Growth | -16.7% | 346.1% | 25% | – |
| Gross Profit | $20 | $31 | $7 | $5 |
| % Margin | 71.5% | 94% | 87% | 88.7% |
| EBITDA | -$14 | -$13 | -$33 | -$35 |
| % Margin | -51.7% | -37.4% | -441.7% | -576.9% |
| Net Income | -$14 | -$19 | -$34 | -$34 |
| % Margin | -51.1% | -56.1% | -449.3% | -570.1% |
| EPS Diluted | -0.16 | -0.21 | -0.39 | -0.41 |
| % Growth | 23.8% | 46.2% | 4.9% | – |
| Operating Cash Flow | $50 | -$36 | -$35 | -$23 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $49 | -$36 | -$35 | -$23 |